Switch theme
Sign up to access all valuation multiples
Topchoice Medical Corp is engaged in providing medical services. The company operates as an integrated medical platform with several oral, health, and reproductive medical institutions.
1995
14
LTM Revenue $411M
LTM EBITDA $128M
$2.7B
Benchmark forward-looking revenue and EBITDA valuation multiples across generative AI, climate tech, semiconductors, online marketplaces, vertical SaaS and 220 more verticals.
Topchoice Medical has a last 12-month revenue (LTM) of $411M and a last 12-month EBITDA of $128M.
In the most recent fiscal year, Topchoice Medical achieved revenue of $399M and an EBITDA of $131M.
Topchoice Medical expects next 12-month revenue of XXX and NTM EBITDA of XXX
See Topchoice Medical valuation multiples based on analyst estimates| LTM | NTM | Last FY | FY 2025 | FY 2026 | FY 2027 | |
|---|---|---|---|---|---|---|
| Revenue | $411M | XXX | $399M | XXX | XXX | XXX |
| Gross Profit | $157M | XXX | $154M | XXX | XXX | XXX |
| Gross Margin | 38% | XXX | 39% | XXX | XXX | XXX |
| EBITDA | $128M | XXX | $131M | XXX | XXX | XXX |
| EBITDA Margin | 31% | XXX | 33% | XXX | XXX | XXX |
| EBIT | $102M | XXX | $97.2M | XXX | XXX | XXX |
| EBIT Margin | 25% | XXX | 24% | XXX | XXX | XXX |
| Net Profit | $72.0M | XXX | $69.6M | XXX | XXX | XXX |
| Net Margin | 18% | XXX | 17% | XXX | XXX | XXX |
| Net Debt | XXX | XXX | n/a | XXX | XXX | XXX |
Financial data powered by Morningstar, Inc.
As of May 30, 2025, Topchoice Medical's stock price is CNY 41 (or $6).
Topchoice Medical has current market cap of CNY 18.5B (or $2.6B), and EV of CNY 19.2B (or $2.7B).
See Topchoice Medical trading valuation data| EV | Market Cap | Price 1D | Price 1M | Price 3M | Price 12M | EPS |
|---|---|---|---|---|---|---|
| $2.7B | $2.6B | XXX | XXX | XXX | XXX | $0.16 |
Sign up to access valuation multiples like growth-adjusted P/E, next 12-month EV/Revenue, EBITDA multiples by industry and many more
Start Free TrialAs of May 30, 2025, Topchoice Medical has market cap of $2.6B and EV of $2.7B.
Topchoice Medical's trades at 6.7x EV/Revenue multiple, and 20.4x EV/EBITDA.
Equity research analysts estimate Topchoice Medical's 2025E EV/Revenue multiple at XXX and 2025E EV/EBITDA multiple at XXX
Topchoice Medical has a P/E ratio of 35.6x.
See valuation multiples for Topchoice Medical and 12K+ public comps| LTM | NTM | Last FY | FY 2025 | FY 2026 | FY 2027 | |
|---|---|---|---|---|---|---|
| Market cap (current) | $2.6B | XXX | $2.6B | XXX | XXX | XXX |
| EV (current) | $2.7B | XXX | $2.7B | XXX | XXX | XXX |
| EV/Revenue | 6.5x | XXX | 6.7x | XXX | XXX | XXX |
| EV/EBITDA | 20.8x | XXX | 20.4x | XXX | XXX | XXX |
| EV/EBIT | 26.3x | XXX | 27.5x | XXX | XXX | XXX |
| EV/Gross Profit | 17.0x | XXX | n/a | XXX | XXX | XXX |
| P/E | 35.6x | XXX | 36.9x | XXX | XXX | XXX |
| EV/FCF | n/a | XXX | 44.6x | XXX | XXX | XXX |
Valuation data powered by FactSet, Inc. and Morningstar, Inc.
Access all public comps and forward-looking valuation multiples like EV/Revenue in 2025, based on equity research analyst estimates.
Start Free TrialTopchoice Medical's last 12 month revenue growth is 8%
Topchoice Medical's revenue per employee in the last FY averaged $28.5M, while opex per employee averaged $4.0M for the same period.
Topchoice Medical's rule of 40 is 41% (metric relevant for SaaS companies only, counted as combined revenue growth rate and EBITDA margin).
Topchoice Medical's rule of X is 51% (created by Bessemer, rule of X is another metric relevant for SaaS companies only, ~1.5x stronger vs. the traditional Rule of 40, counted as revenue growth rate multiplied by 2.5 plus EBITDA margin).
See operational valuation multiples for Topchoice Medical and other 12K+ public comps| LTM | NTM | Last FY | FY 2025 | FY 2026 | FY 2027 | |
|---|---|---|---|---|---|---|
| Revenue Growth | 8% | XXX | 8% | XXX | XXX | XXX |
| EBITDA Margin | 31% | XXX | 33% | XXX | XXX | XXX |
| EBITDA Growth | 12% | XXX | 2% | XXX | XXX | XXX |
| Rule of 40 | 41% | XXX | 41% | XXX | XXX | XXX |
| Bessemer Rule of X | XXX | XXX | 51% | XXX | XXX | XXX |
| Revenue per Employee | XXX | XXX | $28.5M | XXX | XXX | XXX |
| Opex per Employee | XXX | XXX | $4.0M | XXX | XXX | XXX |
| S&M Expenses to Revenue | XXX | XXX | 1% | XXX | XXX | XXX |
| G&A Expenses to Revenue | XXX | XXX | n/a | XXX | XXX | XXX |
| R&D Expenses to Revenue | XXX | XXX | 2% | XXX | XXX | XXX |
| Opex to Revenue | XXX | XXX | 14% | XXX | XXX | XXX |
Valuation data powered by FactSet, Inc. and Morningstar, Inc.
Benchmark public comps and private revenue and EBITDA valuation multiples across GRC software, cloud infrastructure, DevOps, online marketplaces and so much more!
| EV/Revenue | EV/EBITDA | |||||
|---|---|---|---|---|---|---|
| 2025E | 2026E | 2027E | 2025E | 2026E | 2027E | |
| Burjeel Holdings | XXX | XXX | XXX | XXX | XXX | XXX |
| PureHealth | XXX | XXX | XXX | XXX | XXX | XXX |
| Integral Diagnostics | XXX | XXX | XXX | XXX | XXX | XXX |
| Ramsay Health | XXX | XXX | XXX | XXX | XXX | XXX |
| Athens Medical Centre | XXX | XXX | XXX | XXX | XXX | XXX |
| XXXXXXXX | XXX | XXX | XXX | XXX | XXX | XXX |
| XXXXXXXX | XXX | XXX | XXX | XXX | XXX | XXX |
Valuation data powered by FactSet, Inc.
Topchoice Medical acquired XXX companies to date.
Last acquisition by Topchoice Medical was XXXXXXXX, XXXXX XXXXX XXXXXX . Topchoice Medical acquired XXXXXXXX for XXX (EV/Revenue multiple of XXX ).
See M&A valuation multiples| Acquired Company | EV | EV/Revenue | EV/EBITDA |
|---|---|---|---|
| XXXXXXXXX | XXX | XXX | XXX |
| XXXXXXXXX | XXX | XXX | XXX |
| XXXXXXXXX | XXX | XXX | XXX |
| XXXXXXXXX | XXX | XXX | XXX |
| XXXXXXXXX | XXX | XXX | XXX |
Sign up to see revenue and EBITDA valuation multiples for 60K+ M&A deals.
Start Free Trial| When was Topchoice Medical founded? | Topchoice Medical was founded in 1995. |
| Where is Topchoice Medical headquartered? | Topchoice Medical is headquartered in China. |
| How many employees does Topchoice Medical have? | As of today, Topchoice Medical has 14 employees. |
| Is Topchoice Medical publicy listed? | Yes, Topchoice Medical is a public company listed on SHG. |
| What is the stock symbol of Topchoice Medical? | Topchoice Medical trades under 600763 ticker. |
| When did Topchoice Medical go public? | Topchoice Medical went public in 1996. |
| Who are competitors of Topchoice Medical? | Similar companies to Topchoice Medical include e.g. Burjeel Holdings, PureHealth, Integral Diagnostics, Ramsay Health. |
| What is the current market cap of Topchoice Medical? | Topchoice Medical's current market cap is $2.6B |
| What is the current revenue of Topchoice Medical? | Topchoice Medical's last 12 months revenue is $411M. |
| What is the current revenue growth of Topchoice Medical? | Topchoice Medical revenue growth (NTM/LTM) is 8%. |
| What is the current EV/Revenue multiple of Topchoice Medical? | Current revenue multiple of Topchoice Medical is 6.5x. |
| Is Topchoice Medical profitable? | Yes, Topchoice Medical is EBITDA-positive (as of the last 12 months). |
| What is the current EBITDA of Topchoice Medical? | Topchoice Medical's last 12 months EBITDA is $128M. |
| What is Topchoice Medical's EBITDA margin? | Topchoice Medical's last 12 months EBITDA margin is 31%. |
| What is the current EV/EBITDA multiple of Topchoice Medical? | Current EBITDA multiple of Topchoice Medical is 20.8x. |
Get access to always up-to-date, precisely categorized 70K+ public and private valuation multiples, across tech and beyond.
